These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19748500)

  • 21. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease.
    Halfon P; Imbert-Bismut F; Messous D; Antoniotti G; Benchetrit D; Cart-Lamy P; Delaporte G; Doutheau D; Klump T; Sala M; Thibaud D; Trepo E; Thabut D; Myers RP; Poynard T
    Comp Hepatol; 2002 Dec; 1(1):3. PubMed ID: 12537583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus].
    Huang W; Gong FY
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1034-6. PubMed ID: 12433643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.
    Morra R; Munteanu M; Bedossa P; Dargere D; Janneau JL; Paradis V; Ratziu V; Charlotte F; Thibault V; Imbert-Bismut F; Poynard T
    Aliment Pharmacol Ther; 2007 Sep; 26(6):847-58. PubMed ID: 17767469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
    Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B.
    Myers RP; Tainturier MH; Ratziu V; Piton A; Thibault V; Imbert-Bismut F; Messous D; Charlotte F; Di Martino V; Benhamou Y; Poynard T
    J Hepatol; 2003 Aug; 39(2):222-30. PubMed ID: 12873819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
    Poynard T; Halfon P; Castera L; Charlotte F; Le Bail B; Munteanu M; Messous D; Ratziu V; Benhamou Y; Bourlière M; De Ledinghen V;
    Aliment Pharmacol Ther; 2007 Mar; 25(6):733-9. PubMed ID: 17311607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
    Halfon P; Bacq Y; De Muret A; Penaranda G; Bourliere M; Ouzan D; Tran A; Botta D; Renou C; Bréchot MC; Degott C; Paradis V
    J Hepatol; 2007 Mar; 46(3):395-402. PubMed ID: 17156890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical variability of the Fibrotest proteins.
    Rosenthal-Allieri MA; Peritore ML; Tran A; Halfon P; Benzaken S; Bernard A
    Clin Biochem; 2005 May; 38(5):473-8. PubMed ID: 15820779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
    Naveau S; Gaudé G; Asnacios A; Agostini H; Abella A; Barri-Ova N; Dauvois B; Prévot S; Ngo Y; Munteanu M; Balian A; Njiké-Nakseu M; Perlemuter G; Poynard T
    Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2006 Jul; 101(7):1497-9. PubMed ID: 16863552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.
    Sène D; Limal N; Messous D; Ghillani-Dalbin P; Charlotte F; Thiollière JM; Piette JC; Imbert-Bismut F; Halfon P; Poynard T; Cacoub P
    Clin Biochem; 2006 Jul; 39(7):715-21. PubMed ID: 16765932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
    Cacoub P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Perronne C; Pol S; Halfon P
    J Hepatol; 2008 May; 48(5):765-73. PubMed ID: 18314219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data.
    Poynard T; Lassailly G; Diaz E; Clement K; Caïazzo R; Tordjman J; Munteanu M; Perazzo H; Demol B; Callafe R; Pattou F; Charlotte F; Bedossa P; Mathurin P; Ratziu V;
    PLoS One; 2012; 7(3):e30325. PubMed ID: 22431959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive biomarkers FibroTest-ActiTest for replacing invasive liver biopsy: the need for change and action.
    Munteanu M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):173-4. PubMed ID: 17592566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.